Presentation is loading. Please wait.

Presentation is loading. Please wait.

FIGURE 1 Consolidated Standards of Reporting Trials (CONSORT) diagram for the follow-up study. Unless provided in the caption above, the following copyright.

Published byHengki Kusnadi Modified over 5 years ago

Similar presentations

Presentation on theme: "FIGURE 1 Consolidated Standards of Reporting Trials (CONSORT) diagram for the follow-up study. Unless provided in the caption above, the following copyright."— Presentation transcript:

1 FIGURE 1 Consolidated Standards of Reporting Trials (CONSORT) diagram for the follow-up study.
Unless provided in the caption above, the following copyright applies to the content of this slide: Copyright © American Society for Nutrition 2019.This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Am J Clin Nutr, Volume 109, Issue 5, 20 April 2019, Pages 1380–1392, The content of this slide may be subject to copyright: please see the slide notes for details.

2 FIGURE 2 Plot of sex × visit × DHA group interaction for Sentence Repetition task scores. Overall sample sizes are FIGURE 2 Plot of sex × visit × DHA group interaction for Sentence Repetition task scores. Overall sample sizes are 141 at 36 mo (n = 64 and 77 for placebo and DHA, respectively), 160 at 42 mo (n = 73 and 87, respectively), and 151 at 48 mo (n = 72 and 79, respectively). All means shown here are adjusted for covariates and the interaction represented here is statistically significant (P = 0.028). Error bars represent SEMs. Unless provided in the caption above, the following copyright applies to the content of this slide: Copyright © American Society for Nutrition 2019.This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Am J Clin Nutr, Volume 109, Issue 5, 20 April 2019, Pages 1380–1392, The content of this slide may be subject to copyright: please see the slide notes for details.

3 FIGURE 3 Plot of main effect for DHA group on Delayed Response accuracy across visits. Overall sample sizes are 161 at ... FIGURE 3 Plot of main effect for DHA group on Delayed Response accuracy across visits. Overall sample sizes are 161 at 24 mo (n = 77 and 84 for placebo and DHA, respectively) and 160 at 30 mo (n = 84 and 85, respectively). All means shown here are adjusted for covariates. The main effect for DHA group was statistically significant (P = 0.047) but was qualified by several significant higher-order interactions. Error bars represent SEMs. Unless provided in the caption above, the following copyright applies to the content of this slide: Copyright © American Society for Nutrition 2019.This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Am J Clin Nutr, Volume 109, Issue 5, 20 April 2019, Pages 1380–1392, The content of this slide may be subject to copyright: please see the slide notes for details.

4 FIGURE 4 Percentage of children passing the DCCS criterion as a function of age and DHA group. Overall sample sizes ... FIGURE 4 Percentage of children passing the DCCS criterion as a function of age and DHA group. Overall sample sizes are 172 at 36 mo (n = 79 and 93 for placebo and DHA, respectively), 167 at 42 mo (n = 76 and 91, respectively), 167 at 48 mo (n = 78 and 89, respectively), and 158 at 60 mo (n = 74 and 84, respectively). All means shown here are adjusted for covariates and the interaction represented here is statistically significant (P = 0.048). DCCS, Dimensional Change Card Sort. Unless provided in the caption above, the following copyright applies to the content of this slide: Copyright © American Society for Nutrition 2019.This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Am J Clin Nutr, Volume 109, Issue 5, 20 April 2019, Pages 1380–1392, The content of this slide may be subject to copyright: please see the slide notes for details.

5 FIGURE 5 RBC DHA (percentage of total fatty acids) for “Flat” and “Increase” clusters across pregnancy. Overall sample ... FIGURE 5 RBC DHA (percentage of total fatty acids) for “Flat” and “Increase” clusters across pregnancy. Overall sample size at both enrollment and delivery is 263 (n = 97 and 166 for Flat and Increase Clusters, respectively). Error bars represent SEMs. RBC, red blood cell. Unless provided in the caption above, the following copyright applies to the content of this slide: Copyright © American Society for Nutrition 2019.This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Am J Clin Nutr, Volume 109, Issue 5, 20 April 2019, Pages 1380–1392, The content of this slide may be subject to copyright: please see the slide notes for details.

Download ppt "FIGURE 1 Consolidated Standards of Reporting Trials (CONSORT) diagram for the follow-up study. Unless provided in the caption above, the following copyright."

Similar presentations

Unless provided in the caption above, the following copyright applies to the content of this slide: © 2019 European Society of Cardiology and British Pharmacological.

Unless provided in the caption above, the following copyright applies to the content of this slide: © 2019 European Society of Cardiology and British Pharmacological.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 1 Fecal egg counts (eggs per gram = epg) (A through C) and corresponding infection probabilities estimated by ... Figure 1 Fecal egg counts (eggs.

Figure 1 Fecal egg counts (eggs per gram = epg) (A through C) and corresponding infection probabilities estimated by ... Figure 1 Fecal egg counts (eggs.
FIGURE 1 Association of habitual coffee intake with incident of CVD in the UK Biobank and in an earlier meta-analysis ... FIGURE 1 Association of habitual.

FIGURE 1 Association of habitual coffee intake with incident of CVD in the UK Biobank and in an earlier meta-analysis ... FIGURE 1 Association of habitual.
Figure 1 Data-selection process

Figure 1 Data-selection process
Figure 1 Flow diagram detailing the systematic review process.

Figure 1 Flow diagram detailing the systematic review process.
Figure 1 Schematic representation of the experimental design.

Figure 1 Schematic representation of the experimental design.
Figure 1 Number of percutaneous coronary interventions (PCI) in mainland China, 2017 (total 753 142). Data from China ... Figure 1 Number of percutaneous.

Figure 1 Number of percutaneous coronary interventions (PCI) in mainland China, 2017 (total 753 142). Data from China ... Figure 1 Number of percutaneous.
FIGURE 1 Percentage of patients with sarcopenia or low SMD across the spectrum of total adiposity (N = 3262). SMD, ... FIGURE 1 Percentage of patients.

FIGURE 1 Percentage of patients with sarcopenia or low SMD across the spectrum of total adiposity (N = 3262). SMD, ... FIGURE 1 Percentage of patients.
FIGURE 1 PRISMA flow diagram of studies in systematic review

FIGURE 1 PRISMA flow diagram of studies in systematic review
FIGURE 1 Patient enrolment flowchart. SBS, short bowel syndrome.

FIGURE 1 Patient enrolment flowchart. SBS, short bowel syndrome.
FIGURE 1 Flowchart of the study population.

FIGURE 1 Flowchart of the study population.
FIGURE 3 Incidence of anemia by WDDS category at baseline and endpoint

FIGURE 3 Incidence of anemia by WDDS category at baseline and endpoint
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
AHA: American Heart Association; ALT: ...

AHA: American Heart Association; ALT: ...
Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.

Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.
Figure 1 A dot plot illustrating the correlation between the yearly absolute risk difference for both MACE and major ... Figure 1 A dot plot illustrating.

Figure 1 A dot plot illustrating the correlation between the yearly absolute risk difference for both MACE and major ... Figure 1 A dot plot illustrating.
Source: Figure created by the author based on data ...

Source: Figure created by the author based on data ...
(A) OA patients with ... (A) OA patients with crystals exhibit an increase in FA levels in SF compared with OA patients without crystals. (B) Patients.

(A) OA patients with ... (A) OA patients with crystals exhibit an increase in FA levels in SF compared with OA patients without crystals. (B) Patients.
Black: diagnosis ... Black: diagnosis from any department; grey: diagnosis at a rheumatology department. Unless provided in the caption above, the following.

Black: diagnosis ... Black: diagnosis from any department; grey: diagnosis at a rheumatology department. Unless provided in the caption above, the following.

Similar presentations

Ads by Google